Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Stress worsens symptoms and body changes in women with PCOS, especially during COVID-19.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

The document concludes that Passiflora incarnata could help with anxiety, telemedicine might improve heart failure care, screen time for kids has increased, pregnant teens in Brazil are mostly okay with their body image, rare tuberculosis infection can occur after knee surgery, older and severely ill people are more likely to have long COVID-19 symptoms, HPLC might diagnose more diabetes cases, and psychiatrists should be involved in pain management.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

Targeting endolysosomes may help treat COVID-19.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Five FDA-approved drugs may help block COVID-19 virus entry.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Genetic differences affect how people respond to COVID-19.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

The document concludes that Passiflora incarnata may help with anxiety, healthcare workers need mental support, common bacteria cause hospital UTIs, telehealth for heart failure needs research, kids' screen time has increased, pregnant teens are mostly okay with their body image, diagnosing post-surgery tuberculosis is hard, older and severely ill people are more likely to have long COVID symptoms, and psychiatrists should be part of pain management teams.

The pandemic likely caused delays in skin cancer assessments, leading to fewer early diagnoses and thicker melanomas.